Literature DB >> 26582216

The role of tonsillectomy in IgA nephropathy.

Sandro Feriozzi1, Rosaria Polci2.   

Abstract

The IgA nephropathy (IgAN) is a very common glomerulonephritis and can result in end-stage renal disease. From a clinical point of view, IgAN is characterised by repeated events of macrohaematuria associated with infections of the upper airways. In IgAN, the IgA released by the tonsillar lymphatic tissue into blood circulation are defective in glycosylation. These aberrant IgA can reach the glomeruli and deposit into mesangium causing an inflammation with cellular proliferation. The treatment is not yet well defined: steroids and immunosuppressive drugs are suggested in cases with a progressive disease. Tonsillectomy was proposed to reduce the infective events of upper airways and the lymphatic tissue producing undergalactosylated IgA. The experiences in literature coming from Asia report positive effects of tonsillectomy on IgAN. In patients with tonsillectomy, the renal signs improved (less haematuria and proteinuria) and the renal outcome was better (slower progression of renal damage). These were uncontrolled studies and tonsillectomy was associated with steroid and immunosuppressive treatment, so it is not possible to tell the real effect of tonsillectomy. In contrast, the European studies reported that the tonsillectomy was not associated with a better outcome of IgAN. A critical review of the subject reveals that most of the papers with positive results were uncontrolled retrospective experiences, while in a randomised controlled trial paper the advantages of tonsillectomy disappeared. In conclusion, this review, in agreement with the international guidelines, concludes that tonsillectomy does not play any role in the progression of IgAN.

Entities:  

Keywords:  Deglycosylated IgA; IgA nephropathy; Renal failure; Tonsillectomy

Mesh:

Substances:

Year:  2015        PMID: 26582216     DOI: 10.1007/s40620-015-0247-4

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  40 in total

1.  Tonsillectomy has beneficial effects on remission and progression of IgA nephropathy independent of steroid therapy.

Authors:  Isseki Maeda; Tomoshige Hayashi; Kyoko Kogawa Sato; Mikiko Okumoto Shibata; Masahiro Hamada; Masatsugu Kishida; Chizuko Kitabayashi; Takashi Morikawa; Noriyuki Okada; Michiaki Okumura; Masayo Konishi; Yoshio Konishi; Ginji Endo; Masahito Imanishi
Journal:  Nephrol Dial Transplant       Date:  2012-04-05       Impact factor: 5.992

Review 2.  Structure and function relationships in IgA.

Authors:  J M Woof; M W Russell
Journal:  Mucosal Immunol       Date:  2011-09-21       Impact factor: 7.313

Review 3.  Does tonsillectomy have a role in the treatment of patients with immunoglobulin A nephropathy?

Authors:  Ladan Zand; Fernando C Fervenza
Journal:  Nephrol Dial Transplant       Date:  2014-04-10       Impact factor: 5.992

Review 4.  Glycosylation of IgA1 and pathogenesis of IgA nephropathy.

Authors:  Jan Novak; Bruce A Julian; Jiri Mestecky; Matthew B Renfrow
Journal:  Semin Immunopathol       Date:  2012-03-21       Impact factor: 9.623

5.  Influence of tonsillectomy on the progression of mesangioproliferative glomerulonephritis.

Authors:  Antonio Piccoli; Marta Codognotto; Maria-Grazia Tabbi; Enrico Favaro; Barbara Rossi
Journal:  Nephrol Dial Transplant       Date:  2010-03-02       Impact factor: 5.992

6.  Effect of and indication for tonsillectomy in IgA nephropathy.

Authors:  S Tamura; Y Masuda; I Inokuchi; K Terasawa; N Sugiyama
Journal:  Acta Otolaryngol Suppl       Date:  1993

7.  IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria.

Authors:  Rosanna Coppo; Licia Peruzzi; Alessandro Amore; Antonio Piccoli; Pierre Cochat; Rosario Stone; Martin Kirschstein; Tommy Linné
Journal:  J Am Soc Nephrol       Date:  2007-05-18       Impact factor: 10.121

8.  Tonsillectomy and steroid pulse therapy for recurrent IgA nephropathy in renal allograft.

Authors:  T Tsuchiya; S Ito; Y Yamaguchi; Y Moriyama; H Ehara; T Deguchi
Journal:  Clin Nephrol       Date:  2010-01       Impact factor: 0.975

Review 9.  Pathological role of tonsillar B cells in IgA nephropathy.

Authors:  Yusuke Suzuki; Hitoshi Suzuki; Junichiro Nakata; Daisuke Sato; Tadahiro Kajiyama; Tomonari Watanabe; Yasuhiko Tomino
Journal:  Clin Dev Immunol       Date:  2011-07-18

10.  Short and long term impact of adenotonsillectomy on the immune system.

Authors:  Fábio Pires Santos; Raimar Weber; Bibiana Callegaro Fortes; Shirley Shizue Nagata Pignatari
Journal:  Braz J Otorhinolaryngol       Date:  2013 Jan-Feb
View more
  10 in total

1.  Triptolide inhibits tonsillar IgA production by upregulating FDC-SP in IgA nephropathy.

Authors:  Huining Li; Xinxin Yang; Guodong Yao; Yanxiang Zhang; Yangyang Xu; Yan Cao; Xushu An; Haibo Li; Hui Chen; Jingshu Geng; Dawei Yuan; Xiaoming Jin; Hongxue Meng
Journal:  Histol Histopathol       Date:  2019-12-09       Impact factor: 2.303

Review 2.  The Gut and Kidney Crosstalk in Immunoglobulin A Nephropathy.

Authors:  Luis Sanchez-Russo; Arun Rajasekaran; Sofia Bin; Jeremiah Faith; Paolo Cravedi
Journal:  Kidney360       Date:  2022-06-27

3.  Development and Evaluation of a Robust Sandwich Immunoassay System Detecting Serum WFA-Reactive IgA1 for Diagnosis of IgA Nephropathy.

Authors:  Yuta Uenoyama; Atsushi Matsuda; Kazune Ohashi; Koji Ueda; Misaki Yokoyama; Takuya Kyoutou; Kouji Kishi; Youichi Takahama; Masaaki Nagai; Takaaki Ohbayashi; Osamu Hotta; Hideki Matsuzaki
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 6.208

4.  Potential diagnostic biomarkers for IgA nephropathy: a comparative study pre- and post-tonsillectomy.

Authors:  Ying-Xin Xie; Li-Yu He; Xian Chen; Xiao-Fei Peng; Mu-Yao Ye; Yu-Jing Zhao; Wen-Zhe Yan; Chan Liu; Jing Shao; You-Ming Peng
Journal:  Int Urol Nephrol       Date:  2016-07-27       Impact factor: 2.370

Review 5.  IgA Nephropathy: An Interesting Autoimmune Kidney Disease.

Authors:  Arun Rajasekaran; Bruce A Julian; Dana V Rizk
Journal:  Am J Med Sci       Date:  2020-10-08       Impact factor: 2.378

Review 6.  Aberrant IgA1 Glycosylation in IgA Nephropathy: A Systematic Review.

Authors:  Qiang Sun; Zhenhai Zhang; Hong Zhang; Xiaorong Liu
Journal:  PLoS One       Date:  2016-11-21       Impact factor: 3.240

7.  Tripterygium Wilfordii inhibits tonsillar IgA production by downregulating IgA class switching in IgA nephropathy.

Authors:  Huining Li; Dan Kong; Yangyang Xu; Xiaomei Li; Guodong Yao; Kexin Chen; Qi You; Qingtao Shi; Lei Zhang; Xin Wang; Dawei Yuan; Shusheng Miao; Jingshu Geng; Xiaoming Jin; Hongxue Meng
Journal:  Oncotarget       Date:  2017-11-20

8.  C1GALT1 expression is associated with galactosylation of IgA1 in peripheral B lymphocyte in immunoglobulin a nephropathy.

Authors:  Yue Xing; Lina Li; Yaru Zhang; Fanghao Wang; Dandan He; Youxia Liu; Junya Jia; Tiekun Yan; Shan Lin
Journal:  BMC Nephrol       Date:  2020-01-15       Impact factor: 2.388

9.  Tonsillectomy Improved Therapeutic Response in Anti-SRP Myopathy With Chronic Tonsillitis.

Authors:  Takuya Ikeda; Hideyuki Takeuchi; Keita Takahashi; Haruko Nakamura; Misako Kunii; Atsuko Katsumoto; Mikiko Tada; Yuichi Higashiyama; Takashi Hibiya; Shigeaki Suzuki; Ichizo Nishino; Shigeru Koyano; Hiroshi Doi; Fumiaki Tanaka
Journal:  Front Immunol       Date:  2020-11-24       Impact factor: 7.561

10.  Immunoglobulin A nephropathy is characterized by anticommensal humoral immune responses.

Authors:  Elissa G Currie; Bryan Coburn; Elisa A Porfilio; Ping Lam; Olga L Rojas; Jan Novak; Stuart Yang; Raad B Chowdhury; Lesley A Ward; Pauline W Wang; Khashayar Khaleghi; James An; Sarah Q Crome; Michelle A Hladunewich; Sean J Barbour; Daniel C Cattran; Rulan S Parekh; Christoph Licht; Rohan John; Rupert Kaul; Kenneth Croitoru; Scott D Gray-Owen; David S Guttman; Jennifer L Gommerman; Heather N Reich
Journal:  JCI Insight       Date:  2022-03-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.